• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重编程以实现心脏再生:干细胞及其他。

Reprogramming toward heart regeneration: stem cells and beyond.

机构信息

Gene Expression Laboratory, Salk Institute for Biological Studies, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.

出版信息

Cell Stem Cell. 2013 Mar 7;12(3):275-84. doi: 10.1016/j.stem.2013.02.008.

DOI:10.1016/j.stem.2013.02.008
PMID:23472869
Abstract

Finding a cure for cardiovascular disease remains a major unmet medical need. Recent investigations have started to unveil the mechanisms of mammalian heart regeneration. The study of the regenerative mechanisms in lower vertebrate and mammalian animal models has provided clues for the experimental activation of proregenerative responses in the heart. In parallel, the use of endogenous adult stem cell populations alongside the recent application of reprogramming technologies has created major expectations for the development of therapies targeting heart disease. Together, these new approaches are bringing us closer to more successful strategies for the treatment of heart disease.

摘要

寻找心血管疾病的治疗方法仍然是一个未满足的主要医学需求。最近的研究开始揭示哺乳动物心脏再生的机制。对低等脊椎动物和哺乳动物动物模型的再生机制的研究为实验激活心脏的促再生反应提供了线索。与此同时,内源性成体干细胞群体的利用以及最近的重编程技术的应用,为针对心脏病的治疗方法的发展带来了重大期望。这些新方法共同使我们更接近于治疗心脏病的更成功策略。

相似文献

1
Reprogramming toward heart regeneration: stem cells and beyond.重编程以实现心脏再生:干细胞及其他。
Cell Stem Cell. 2013 Mar 7;12(3):275-84. doi: 10.1016/j.stem.2013.02.008.
2
[Regenerative medicine for heart disease].[心脏病的再生医学]
Nihon Rinsho. 2003 Mar;61(3):480-4.
3
Growing vascularized heart tissue from stem cells.从干细胞中培育具有血管化的心脏组织。
J Cardiovasc Pharmacol. 2013 Aug;62(2):122-9. doi: 10.1097/FJC.0b013e31829372fc.
4
Stem cells offer promise--not more--for heart disease. Much as we need a way to fix damaged heart muscle, stem cell therapy isn't just around the corner.干细胞为治疗心脏病带来了希望——但仅此而已。尽管我们迫切需要修复受损心肌的方法,但干细胞疗法并非指日可待。
Harv Heart Lett. 2006 Jul;16(11):4.
5
Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy.提高基于细胞编程的心脏再生治疗方法的策略和挑战。
Int J Mol Sci. 2020 Oct 16;21(20):7662. doi: 10.3390/ijms21207662.
6
Myocardial regeneration with stem cells: pharmacological possibilities for efficacy enhancement.干细胞介导的心肌再生:增强疗效的药理学途径
Pharmacol Res. 2006 Apr;53(4):331-40. doi: 10.1016/j.phrs.2006.01.009. Epub 2006 Feb 28.
7
Direct reprogramming of fibroblasts into myocytes to reverse fibrosis.将成纤维细胞直接重编程为心肌细胞以逆转纤维化。
Annu Rev Physiol. 2014;76:21-37. doi: 10.1146/annurev-physiol-021113-170301. Epub 2013 Sep 20.
8
The heart's content-renewable resources.心中的满足——可再生资源。
Int J Cardiol. 2013 Aug 20;167(4):1141-6. doi: 10.1016/j.ijcard.2012.09.051. Epub 2012 Oct 6.
9
Extracellular Matrix and Regenerative Therapies from the Cardiac Perspective.从心脏角度看细胞外基质和再生疗法。
Stem Cell Rev Rep. 2016 Apr;12(2):202-13. doi: 10.1007/s12015-015-9641-5.
10
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.

引用本文的文献

1
The generation of a lactate-rich environment stimulates cell cycle progression and modulates gene expression on neonatal and hiPSC-derived cardiomyocytes.产生富含乳酸的环境会刺激细胞周期进程,并调节新生儿和 hiPSC 衍生的心肌细胞的基因表达。
Biomater Adv. 2022 Aug;139:213035. doi: 10.1016/j.bioadv.2022.213035. Epub 2022 Jul 20.
2
scREMOTE: Using multimodal single cell data to predict regulatory gene relationships and to build a computational cell reprogramming model.scREMOTE:利用多模态单细胞数据预测调控基因关系并构建计算细胞重编程模型。
NAR Genom Bioinform. 2022 Mar 15;4(1):lqac023. doi: 10.1093/nargab/lqac023. eCollection 2022 Mar.
3
Restoring Ravaged Heart: Molecular Mechanisms and Clinical Application of miRNA in Heart Regeneration.
修复受损心脏:微小RNA在心脏再生中的分子机制与临床应用
Front Cardiovasc Med. 2022 Feb 10;9:835138. doi: 10.3389/fcvm.2022.835138. eCollection 2022.
4
Strategies and Challenges to Improve Cellular Programming-Based Approaches for Heart Regeneration Therapy.提高基于细胞编程的心脏再生治疗方法的策略和挑战。
Int J Mol Sci. 2020 Oct 16;21(20):7662. doi: 10.3390/ijms21207662.
5
Bioactive Lipid Signaling in Cardiovascular Disease, Development, and Regeneration.生物活性脂质信号在心血管疾病、发育和再生中的作用。
Cells. 2020 Jun 3;9(6):1391. doi: 10.3390/cells9061391.
6
Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods.使用定性和定量组织学方法分析小鼠胚胎中的先天性心脏缺陷
J Vis Exp. 2020 Mar 10(157). doi: 10.3791/60926.
7
Loss of genomic integrity induced by lysosphingolipid imbalance drives ageing in the heart.溶血性神经酰胺失衡引起的基因组完整性丧失导致心脏衰老。
EMBO Rep. 2019 Apr;20(4). doi: 10.15252/embr.201847407. Epub 2019 Mar 18.
8
Non-coding RNA function in stem cells and Regenerative Medicine.非编码RNA在干细胞与再生医学中的功能
Noncoding RNA Res. 2018 Apr 20;3(2):39-41. doi: 10.1016/j.ncrna.2018.04.004. eCollection 2018 Jun.
9
Non-coding microRNAs for cardiac regeneration: Exploring novel alternatives to induce heart healing.用于心脏再生的非编码微小RNA:探索诱导心脏愈合的新方法。
Noncoding RNA Res. 2017 May 17;2(2):93-99. doi: 10.1016/j.ncrna.2017.05.001. eCollection 2017 Jun.
10
Therapeutic Potential of Adipose Stem Cells.脂肪干细胞的治疗潜力。
Adv Exp Med Biol. 2021;1341:15-25. doi: 10.1007/5584_2018_248.